Stellarex clinical evidence

The Stellarex below-the-knee 0.014" drug-coated angioplasty balloon is built on the same platform as our 0.035″ above-the-knee DCB, which has demonstrated consistently high patency rates and safety in a wide range of patients across multiple clinical trials.

0.014" DCB is not approved for distribution, sale or use in the USA.
Availability of this product may vary by country.

Robust ILLUMENATE clinical trial series

Stellarex is the only commercially available DCB for the SFA with two reported randomized controlled trials, four other clinical trials (N = 1,079)6 and the largest number of randomized patients (N = 628).6 Across clinical trials, Stellarex delivers consistent results.

ILLUMENATE Clinical Trial Series BTK

Now enrolling for BTK trials

Watch the clinical outcomes video

Play video